Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-PPDS in Ocular Hypertension or Open-Angle Glaucoma
NCT02014142Phase 2Completed
- Sponsor
- Mati Therapeutics
- Start
- Dec 2013
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost in ocular hypertension, open-angle glaucoma (OAG), sponsored by Mati Therapeutics. Started Dec 2013; status: completed.
02
Drugs
latanoprost
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT02014142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014142.